Citigroup upgraded Eastman Chemical's outlook from Neutral to Buy on April 4, 2025, with a one-year price target averaging 113.90 GBX/share, indicating a potential 38.74% upside from its recent closing price of 82.09 GBX/share. Projected annual revenue is expected to rise by 21.59% to 11,408MM, with a non-GAAP EPS forecast of 9.96. Institutional ownership has increased, with 1,414 funds reporting positions, reflecting a 6.42% rise in total shares owned over the last three months.